The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation

American Journal of Transplantation

Volumn 2, Issue 7, 2002, Pages 640-645

  Schröppel, Bernd ^a,b   Fischereder, Michael ^c   Ashkar, Rami ^a   Lin, Marvin ^a   Krämer, Bernhard K ^c   Marder, Brad ^a   Schiano, Tom ^a   Murphy, Barbara ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

CCR2; CCR5; Graft survival; Rejection; SDF1

Indexed keywords

CHEMOKINE; CYTOKINE RECEPTOR;

ADULT; ALLOGRAFT; ARTICLE; EPITHELIUM CELL; FEMALE; GENE TRANSFER; GENETIC POLYMORPHISM; GENOTYPE; GRAFT SURVIVAL; HETEROZYGOTE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; RECIPIENT; T LYMPHOCYTE ACTIVATION;

CHEMOKINES; CHEMOKINES, CXC; ETHNIC GROUPS; FEMALE; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036705376     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20709.x     Document Type: Article

References (30)

1. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000; 18: 593-620.
2. Winkler C, Modi W, Smith MW et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998; 279: 389-393.
3. Smith MW, Dean M, Carrington M et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997; 277: 959-965.
4. Barcellos LF, Schito AM, Rimmler JB et al. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics 2000; 51: 281-288.
5. Gomez-Reino JJ, Pablos JL, Carreira PE et al. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthr Rheum 1999; 42: 989-992.
6. Petrek M, Drabek J, Kolek V et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000; 162: 1000-1003.
7. Herfarth H, Pollok-Kopp B, Goke M, Press A, Oppermann M. Polymorphism of CC chemokine receptors CCR2 and CCR5 in Crohn's disease. Immunol Lett 2001; 77: 113-117.
8. Hancock WW, Gao W, Faia KL, Csizmadia V. Chemokines and their receptors in allograft rejection. Curr Opin Immunol 2000; 12: 511-516.
9. Nelson PJ, Krensky AM. Chemokines, chemokine receptors and allograft rejection. Immunity 2001; 14: 377-386.
10. Akalin E, Murphy B. Gene polymorphisms and transplantation. Curr Opin Immunol 2001; 13: 572-576.
11. Adams DH, Hubscher S, Fear J, Johnston J, Shaw S, Afford S. Hepatic expression of macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta after liver transplantation. Transplantation 1996; 61: 817-825.
12. Morland CM, Fear J, McNab G, Joplin R, Adams DH. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc Assoc Am Physicians 1997; 109: 372-382.
13. Schenk M, Zipfel A, Schulz C, Becker HD, Viebahn R. RANTES in the postoperative course after liver transplantation. Transpl Int 2000; 13 (Suppl. 1): S147-S149.
14. Goddard S, Williams A, Morland C et al. Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation 2001; 72: 1957-1967.
15. Gao W, Faia KL, Csizmadia V et al. Beneficial effects of targeting ccr5 in allograft recipients. Transplantation 2001; 72: 1199-1205.
16. Gröne HJ, Weber C, Weber K et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 1999; 13: 1371-1383.
17. Belperio JA, Burdick MD, Keane MP et al. The role of the CC chemokine, RANTES, in acute lung allograft rejection. J Immunol 2000; 165: 461-472.
18. Fischereder M, Luckow B, Hocher B et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001; 357: 1758-1761.
19. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997; 16: 100-103.
20. Slavcheva E, Albanis E, Jiao Q et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection. Transplantation 2001; 72: 935-940.
21. Bathgate AJ, Pravica V, Perrey C et al. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta 1 genes in acute hepatic allograft rejection. Transplantation 2000; 69: 1514-1517.
22. Jonsson JR, Hong C, Purdie DM et al. Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation. Liver Transpl 2001; 7: 255-263.
23. Tambur AR, Ortegel JW, Ben-Ari Z et al. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation 2001; 71: 1475-1480.
24. Wu L, Paxton WA, Kassam N et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997; 185: 1681-1691.
25. Samson M, Libert F, Doranz BJ et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996; 382: 722-725.
26. Pablos JL, Amara A, Bouloc A et al. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am J Pathol 1999; 155: 1577-1586.
27. Dubois-Laforgue D, Hendel H, Caillat-Zucman S et al. A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 2001; 50: 1211-1213.
28. Buckley CD, Amft N, Bradfield PF et al. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 2000; 165: 3423-3429.
29. Libby P, Pober JS. Chronic rejection. Immunity 2001; 14: 387-397.
30. Chen BP, Kuziel WA, Lane TE. Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J Immunol 2001; 167: 4585-4592.